Use of antioxidants in means of treating halitosis

Information

  • Patent Application
  • 20040067204
  • Publication Number
    20040067204
  • Date Filed
    November 03, 2003
    20 years ago
  • Date Published
    April 08, 2004
    20 years ago
Abstract
Antioxidants or antioxidant-contaming preparations for producing compositions are used for eliminating halitosis or preventing the formation of halitosis. According to the invention, the antioxidants used can be all antioxidants which are suitable or customary for oral hygiene applications. In particular, vitamins and coenzyme come into consideration as antioxidants. Those which also come into consideration are, for example, amino acids, imidazoles, peptides, fatty acids, metal compounds and derivatives of these compounds (for example salts, esters, ethers, sugars, nucleotides, nucleosides).
Description


[0001] The use of antioxidants in the oral and throat cavity is known in principle from the prior art. Thus JP 61286314 discloses the use of vitamins, for example vitamin E, vitamin B6, for treating paradontosis, in particular gingivitis.


[0002] In addition, WO 94/06418 discloses the use of coenzyme Q 10 for the therapeutic treatment of paradontosis.


[0003] To control bad breath (halitosis), according to the prior art, bactericidal compositions (for example Triclosan) or aroma compounds (menthol, menthol derivatives or mint aromas) are used. These compositions have the disadvantage that they are only effective against bad breath caused by bacteria.


[0004] It is an object of the present invention, therefore, to provide a composition which no longer has the disadvantages described in the prior art.


[0005] This object is achieved according to the invention by using antioxidants or antioxidant-containing preparations for producing compositions for eliminating halitosis or preventing the formation of halitosis.


[0006] According to the invention, the antioxidants used can be all antioxidants which are suitable or customary for oral hygiene applications. In particular, vitamins and coenzyme come into consideration as antioxidants. Those which also come into consideration are, for example, amino acids, imidazoles, peptides, fatty acids, metal compounds and derivatives of these compounds (for example salts, esters, ethers, sugars, nucleotides, nucleosides).


[0007] Preferably, the antioxidants are selected from the group consisting of amino acids (for example glycine, histidine, tyrosine, tryptophan) and derivatives thereof, imidazoles (for example urocanic acid) and derivatives thereof, peptides such as D,L-carnosine, D-carnosine, L-carnosine and derivatives thereof (for example anserine), carotenoids, carotenes (for example α-carotene, β-carotene, lycopene) and derivatives thereof, lipoic acid and derivatives thereof (for example dihydrolipoic acid), aurothioglucose, propylthiouracil and other thiols (for example thioredoxin, glutathione, cysteine, cystine, cystamine and glycosyl, N-acetyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, α-linoleyl, γ-linoleyl, cholesteryl, glyceryl, and oligoglyceryl esters thereof) and salts thereof, dilauryl thiodipropionate, disteaiyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (for example buthionine sulfoximines, homocysteine sulfoxirnine, buthionine sulfones, penta-, hexa-, heptathionine sulfoximine) in very low tolerable doses (for example pmol to pmol/kg), in addition (metal) chelators (for example α-hydroxy fatty acids, fatty acids (palmitic acids), phytic acid, lactoferrin, EDTA, EGTA), α-hydroxy acids (for example citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, unsaturated fatty acids and derivatives thereof (for example palmitoleic acid, α-linolnic acid, γ-linolenic acid, linoleic acid, oleic acid), folic acid and derivatives thereof, ubiquinone and ubiquinol and derivatives thereof, vitamin C and derivatives (for example α-ascorbyl palmitate, Mg—ascorbyl phosphate, ascorbyl acetate), tocopheroles and derivatives (for example vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin gum, rutinic acid and derivatives thereof, ferulic acid and derivatives thereof, butylated hydroxy toluene, butylated hydroxyanisole, nordihydroguaiac resin acid, nordihydroguaiaretic acid, trihydroxybutyrophenone, uric acid and derivatives thereof, mannose and derivatives thereof, zinc and derivatives thereof (for example, ZnO, ZnSO4), selenium and derivatives thereof (for example selenomethionine), stilbenes and derivatives thereof (for example stilbene oxide, trans-stilbene oxide) and the inventively suitable derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of said active compounds.


[0008] Particular preference is given according to the invention to vitaminn C, vitamin E, vitamin A, plastoquinone, menaquinone, ubiquinols 1-10, ubiquinones 1-10 or derivatives of these substances.


[0009] Very particular preference is given to ubiquinols 1-10 and/or derivatives thereof and ubiquinones 1-10 and derivatives thereof Very high preference is given to use of coenzyme Q10.


[0010] The amount of the antioxidants (one or more compounds) in the preparations is preferably 0,001 to 30% by weight, particularly preferably 0.05-20% by weight, in particular 1-10% by weight, based on the total weight of the preparation.


[0011] If ubiquinone and/or derivatives thereof and/or ubiquinol and/or derivatives thereof, vitamin C and/or derivatives thereof, vitamin E and/or derivatives thereof, vitamin A, or vitamin A derivatives, or carotenes or derivatives thereof are used as antioxidants, it is advantageous to select their respective concentrations from the range 0.001-10% by weight, based on the total weight of the preparation.


[0012] The present invention is based on the principle of controlling halitosis by topical application of the abovementioned antioxidants, in particular coenzyme Q10, to the oral and throat mucosa via the usual means. According to the invention, the antioxidants can therefore be used in combination with all customary compositions, in particular the customary oral-care and oral-cleaning preparations known to those skilled in the art. In particular, those which can be used are, in addition to the antioxidants, bactericidal compositions (Triclosan) and/or aroma substances (menthol, menthol derivatives, mint aromas). Surprisingly, the use of said antioxidants leads to a detectable reduction in bad breath odor.


[0013] Examples of use are, especially, toothpastes, tooth powders and mouth washes. However, the use of the antioxidants can also come into consideration in any other compositions which are used for treating the oral and throat cavity.


[0014] The active compounds according to the invention can be used particularly advantageously in opaque, translucent and transparent microemulsions and/or nanoemulsions. Preparations according to the invention can be used particularly advantageously as


[0015] a) unthickened oil-in-water (o/w), bicontinuous or water-in-oil (w/o) micro- and/or nanoemulsions,


[0016] b) oil-in-water (o/w), bicontinuous or water-in-oil (w/o) micro- and/or nanoemulsions classically thickened, for example by using polyoxamers, pluronics, carrageenans or vegetable gums,


[0017] c) thickened by adding A-B-A triblock copolymers (for example PEG-150-distearate, from Akzo Nobel) or alpha, omega-bis-polyethoxlated silanes or silicones),


[0018] d) thickened by adding star polymers (for example PEG-300-pentaerythrityl tetrastearate or hydrophobically modified tetrakis-polyethoxylated silanes and silicones),


[0019] e) oil-in-water (o/w), bicontinuous or water-in-oil (w/o) micro- and/or nanoemulsions thickened by adding A-B-A-B multiblock copolymers, starburst polymers, dendrimers and other supramolecular crosslinkers (for example Rheodols, TWIS 399, from KAO, or PEG-120 methylglucose dioleate).






EXAMPLES


Formulation Examples

[0020] 1. Gel Toothpaste Having Activity Against Halitosis
1Base: Silica, sodium fluorideI (%)II (%)III (%)Na carboxymethylcellulose0.400.400.40Sorbitol, 70%72.0072.0072.00PEG 15003.003.003.00Na saccharinate0.070.070.07Na fluoride0.240.240.24PHB ethyl ester0.150.150.15Aroma1.01.001.00D,L-carnosine0.10N-acetylcysteine0.10EDTA0.10Abrasive silica11.0011.0011.00Silica thickener6.006.006.00SDS1.401.401.40Distilled waterto 100.00to 100.00to 100.00


[0021] 2. Antiplacque Toothpaste Having Activity Against Halitosis
2Base: Silica, AHPI (%)II (%)III (%)Na carboxymethylcellulose1.001.001.00Glycerol 86%12.5012.5012.50Sorbitol 70%29.0029.0029.00Na saccharinate0.200.200.20Na fluoride0.220.220.22Azacycloheptane-2,2-diphosphonic1.001.001.00acid, disodium salt (AHP)Bromochlorophen0.100.100.10Aroma1.101.101.10ZnSO40.20Coenzyme Q100.20Retinyl palmitate0.20Abrasive silica15.0015.0015.00Silica thickening5.005.005.00SDS1.501.501.50Distilled waterto 100.00to 100.00to 100.00


[0022] 3. Antiplacque Toothpaste Having Activity Against Halitosis
3Base: Silica, alkali metal diphosphateI (%)II (%)III (%)Carrageenan0.900.900.90Glycerol 86%15.0015.0015.00Sorbitol 70%25.0025.0025.00PEG 10003.003.003.00Na fluoride0.240.240.24Tetrapotassium4.504.504.50diphosphateTetrasodium diphosphate1.501.501.50Na saccharinate0.400.400.40Silica precipitant20.0020.0020.00Titanium dioxide1.001.001.00PHB methyl ester0.100.100.10Aroma1.101.101.10Lipoic acid0.25α-Hydroxypalmitic acid0.25Folic acid0.25SDS1.301.301.30Distilled waterto 100.00to 100.00to 100.00


[0023] 4. Toothpaste for Sensitive Teeth Having Activity Against Halitosis
4Base: Ca carbonate, K nitrateI (%)II (%)III (%)Na carboxymethylcellulose0.700.700.70Xanthan gum0.500.500.50Glycerol 86%15.0015.0015.00Sorbitol 70%12.0012.0012.00K nitrate5.005.005.00Na monofluorophosphate0.800.800.80PHB methyl ester0.150.150.15PHB propyl ester0.050.050.05Na saccharinate0.200.200.20Aroma1.001.001.00Oleic acid0.10Glycerol monolaurate0.10Thiodipropionic acid0.10Ca carbonate35.0035.0035.00Silicon dioxide1.001.001.00SDS1.501.501.50Distilled waterto 100.00to 100.00to 100.00


[0024] 5. Toothpaste for Sensitive Teeth Having Activity Against Halitosis
5Base: Silica, strontium chlorideI (%)II (%)III (%)Hydroxyethylcellulose1.401.401.40Guar gum0.600.600.60Glycerol 86%18.0018.0018.00Sorbitol 70%12.0012.0012.00Na saccharinate0.350.350.35Dye0.010.010.01PHB methyl ester0.150.150.15PHB propyl ester0.040.040.04Sr chloride10.5010.5010.50Aroma1.201.201.20Urocanic acid0.05Coenzyme Q100.05Lactic acid0.05Silica precipitant15.0015.0015.00Silicon dioxide1.601.601.60SDS1.301.301.30Distilled waterto 100.00to 100.00to 100.00


[0025] 6. Ready-To-Use Mouthwash Having Fluoride and Activity Against Halitosis
6Base: Ethanol, Na fluorideI (%)II (%)III (%)Ethanol 94.7%7.007.007.00Glycerol 86%12.0012.0012.00Na fluoride0.050.050.05Pluronic F-1271.401.401.40Na phosphate buffer pH1.101.101.107.0Sorbic acid0.200.200.20Na saccharinate0.100.100.10Aroma0.150.150.15Ascorbic acid0.20Trihydroxybutyrophenone0.20Mannose0.20Dye0.010.010.01Distilled waterto 100.00to 100.00to 100.00


[0026] 7. Mouthwash Concentrate Having Activity Against Halitosis
7Base: Ethanol, aromaI (%)II (%)III (%)Ethanol 94.7%80.0080.0080.00Na cyclamate0.150.150.15Aroma3.503.503.50Dye0.010.010.01Coenzyme Q100.10Distearyl thiodipropionate0.01Rutic acid0.10Distilled waterto 100.00to 100.00to 100.00


[0027] 8. Mouthwash
81,3-di(2-ethylhexyl)cyclohexane35.00Glyceryl lanolate5.00Sorbitan monolaurate10.00Water (+ citric acid to pH 5.5)45.00


[0028] The abovementioned example can also be formulated with an identical amount of retinyl palmitate, tocopheryl acetate. mannose or lycopene, instead of glyceryl lanolate.


[0029] 9. Mouthwash
91,3-di(2-ethylhexyl)cyclohexane33.00Histidine0.50Sorbitan monolaurate10.00Water (+ citric acid to pH 5.5)45.00PEG-150 distearate2.00


[0030] The abovementioned example can also be formulated using an identical amount of D,L-carnosine, ascorbic acid, humic acid or coenzyme Q10.


[0031] 10. Throat Wash
10Steareth-154.80Glycerol monostearate2.40Glyceryl lanolate2.50Cyclomethicone3.30Cetearyl octanoate1.70Water85.30


[0032] The abovementioned example can also be formulated using an identical amount of oleic acid monoglyceride, triglycerol monolaurate or glycerol mono palmitate instead of glyceryl lanolate.


[0033] 11. Throat Wash
11Steareth-154.80Mg ascorbyl phosphate0.20Cholestryl hydroxystearate2.50Cyclomethicone3.30Cetearyl octanoate17.00Water83.30PEG-1500 distearate2.00


[0034] The abovementioned example can also be formulated using an identical amount of coenzyme Q 10, retinyl palmitate, tocopheryl acetate or lycopene, instead of Mg ascorbyl phosphate.


Claims
  • 1. The use of antioxidants or antioxidant-containing preparations for preparing compositions for eliminating halitosis or for preventing the formation of halitosis.
  • 2. The use as claimed in claim 1, characterized in that the antioxidants are used in amounts of 0.001-30% by weight (based on the total weight of the preparation).
  • 3. The use as claimed in claim 1, characterized in that the antioxidants are used in amounts of 0.05-20% by weight (based on the total weight of the preparation).
  • 4. The use as claimed in claim 1, characterized in that the antioxidants are used in amounts of 0.05-20% by weight (based on the total weight of the preparation).
  • 5. The use as claimed in claim 1, characterized in that the antioxidants are used in amounts of 1-10% by weight (based on the total weight of the preparation).
  • 6. The use as claimed in claim 1, characterized in that the antioxidants made up are vitamins and coenzymes and derivatives of these substances.
  • 7. The use as claimed in claim 1, characterized in that the antioxidants used are ubiquinone and ubiquinol, vitamin C, vitamin A and vitamin B and derivatives of these substances.
  • 8. The use as claimed in claim 1, characterized in that ubiquinone 1-10, ubiquinol 1-10, menaquinone are used.
  • 9. The use as claimed in one of claim 1, characterized in that a scorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate, vitamin E acetate, vitamin A palmitate are used.
  • 10. The use as claimed in one of claim 1, characterized in that coenzyme Q 10 is used.
  • 11. The use as claimed in one of claim 1, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes, carotenoids and the derivatives of these compounds are used in amounts of 0.001-10% by weight (based on the total weight of the preparation).
  • 12. The use as claimed in one of claim 1, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes and derivatives of these compounds are used in amounts of 0.01-5% by weight based on the total weight of the preparation.
  • 13. The use as claimed in one of claim 1, characterized in that ubiquinone, ubiquinol, vitamin B, vitamin E, vitamin A, carotenes and the derivatives of these compounds are used in amounts of 0.1-2.5% by weight based on the total weight of the preparation.
Priority Claims (1)
Number Date Country Kind
100 62 770.6 Dec 2000 DE
PCT Information
Filing Document Filing Date Country Kind
PCT/EP01/14099 12/3/2001 WO